12:00 AM
 | 
Jan 09, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Xeomin incobotulinumtoxinA regulatory update

Merz said the Centers for Medicare & Medicaid Services (CMS) issued a permanent J-code for reimbursement of Xeomin incobotulinumtoxinA. J0588,...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >